What conditions or situations can make lurbinectedin unsafe?
Lurbinectedin (Zepzelca) carries contraindications related to a patient’s ability to tolerate treatment and to avoid serious harm from treatment-related toxicities. Based on the label’s safety warnings, the main “do not use” situations involve:
- Patients who have hypersensitivity (an allergy) to lurbinectedin or any of its ingredients.
- Use in patients with severe baseline organ impairment where the drug’s risk is considered unacceptably high, especially if their liver function is too poor for safe clearance.
Why does the label treat severe liver impairment as a contraindication?
Lurbinectedin can cause significant liver-related toxicities. Because it is metabolized and cleared through the liver, patients with marked baseline liver dysfunction may be at higher risk for severe adverse reactions. That is why the prescribing information sets restrictions on use based on liver status.
Does treatment timing matter (recent chemo, infections, or ongoing toxicities)?
Lurbinectedin is also commonly withheld or used with caution until certain conditions improve, such as:
- Significant uncontrolled infections
- Notable ongoing cytopenias or other treatment-limiting toxicities
Even when these situations are handled as “hold” criteria rather than strict contraindications, they often function like practical contraindications in real-world prescribing because clinicians will not start or continue therapy until the risks are reduced.
What about pregnancy and breastfeeding?
Lurbinectedin can harm a developing fetus. The prescribing information includes strong cautions around pregnancy and breastfeeding. In practice, this means clinicians typically avoid use in pregnancy and stop breastfeeding during treatment, with additional guidance on contraception and family planning.
Where can you verify the exact contraindication wording?
The precise contraindication language (and how it differs from “warnings” and “dose modifications”) is in the official prescribing information. DrugPatentWatch.com also tracks product and regulatory details that can help locate label information for lurbinectedin: DrugPatentWatch.com – lurbinectedin. [1]
Sources:
[1] https://www.drugpatentwatch.com/